Urokinase and plasminogen activator inhibitor type 1 in pulmonary adenocarcinoma von Pedersen, H, Grøndahl-Hansen, J, Francis, D, Osterlind, K, Hansen, H H, Danø, K, Brünner, N

Volltext

Antagonistic effect of aclarubicin on daunorubicin-induced cytotoxicity in human small cell lung cancer cells: relationship to DNA integrity and topoisomerase II von Jensen, P B, Jensen, P S, Demant, E J, Friche, E, Sørensen, B S, Sehested, M, Wassermann, K, Vindeløv, L, Westergaard, O, Hansen, H H

Volltext

Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue von PEDERSEN, H, BRÜNNER, N, FRANCIS, D, ØSTERLIND, K, RØNNE, E, HANSEN, H, DANØ, K, GRØNDAHL-HANSEN, J

Volltext

Antagonistic effect of aclarubicin on the cytotoxicity of etoposide and 4'-(9-acridylamino)methanesulfon-m-anisidide in human small cell lung cancer cell lines and on topoisomerase... von JENSEN, P. B, SOÊRENSEN, B. S, DEMANT, E. J. F, SEHESTED, M, JENSEN, P. S, VINDELOÊV, L, HANSEN, H. H

Volltext

Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients von LASSEN, U, ØSTERLIND, K, HANSEN, M, DOMBERNOWSKY, P, BERGMAN, B, HANSEN, H. H

Volltext

Determinants of complete remission induction and maintenance in chemotherapy with or without irradiation of small cell lung cancer von ØSTERLIND, K, HØI HANSEN, H, DOMBERNOWSKY, P, HANSEN, M, KRAGH ANDERSEN, P

Volltext

Paclitaxel, gemcitabine, and cisplatin in non-resectable, non-small cell lung cancer (NSCLC) von Sorensen, Jens B., Stenbygaard, Lars Erik, Osterlind, Kell, Hansen, Heine Høi

Volltext

The effect of the two epipodophyllotoxin derivatives etoposide (VP-16) and teniposide (VM-26) on cell lines established from patients with small cell carcinoma of the lung von ROED, H, VINDELOV, L. L, CHRISTENSEN, I. J, SPANG-THOMSEN, M, HANSEN, H. H

Volltext

Different modes of anthracycline interaction with topoisomerase II: Separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistance von Jensen, Peter Buhl, Sørensen, Boe Sandahl, Sehested, Maxwell, Demant, Erland J.F., Kjeldsen, Eigil, Friche, Ellen, Hansen, Heine Høi

Volltext

Current therapy of small cell lung cancer von Sorensen, Morten, Lassen, Ulrik, Hansen, Heine Høi

Volltext

SUPPRESSION OF INHIBITORS von PYKE CHARLES, GRONDAHL-HANSEN JAN, PAPPOT HELLE PEDERSEN, ELLIS VINCENT, BRUNNER NIELS, DANO KELD, ROMER JOHN, HANSEN HEINE HOI

Volltext bestellen

15 Outcome of combination chemotherapy in extensive stage small cell lung cancer: Any treatment related progress? von Lassen, Ulrick N., Hirsch, Fred R., Østerlind, Kell, Bergman, Bengt, Dombernowsky, Per, Hansen, Heine Høi

Volltext

UNTERDRÜCKUNG VON INHIBITOREN von PEDERSEN, HELLE, HANSEN, HEINE, HOI, GRONDAHL-HANSEN, JAN, PYKE, CHARLES, ROMER, JOHN, ELLIS, VINCENT, DANO, KELD, BRUENNER, NILS

Volltext bestellen

SUPPRESSION OF INHIBITORS von PEDERSEN, HELLE, HANSEN, HEINE, HOI, GRONDAHL-HANSEN, JAN, PYKE, CHARLES, ROMER, JOHN, ELLIS, VINCENT, DANO, KELD, BRUENNER, NILS

Volltext bestellen

Suppression of inhibitors von PYKE CHARLES, GRONDAHL-HANSEN JAN, PAPPOT HELLE PEDERSEN, ELLIS VINCENT, BRUNNER NIELS, DANO KELD, ROMER JOHN, HANSEN HEINE HOI

Volltext bestellen

In vivo inhibition of etoposide-mediated apoptosis, toxicity, and antitumor effect by the topoisomerase II-uncoupling anthracycline aclarubicin von HOLM, B, JENSEN, P. B, SEHESTED, M, HANSEN, H. H

Volltext

Suppression of inhibitors von PYKE CHARLES, GRONDAHL-HANSEN JAN, PAPPOT HELLE PEDERSEN, ELLIS VINCENT, BRUNNER NIELS, DANO KELD, ROMER JOHN, HANSEN HEINE HOI

Volltext bestellen

Small cell lung cancer: biological and therapeutic aspects von Kristensen, Claus A., Jensen, Peter B., Poulsen, Hans S., Hansen, Heine H.

Volltext

SUPPRESSION OF INHIBITORS von PEDERSEN, HELLE, HANSEN, HEINE, HOI, GRONDAHL-HANSEN, JAN, PYKE, CHARLES, ROMER, JOHN, ELLIS, VINCENT, DANO, KELD, BRUENNER, NILS

Volltext bestellen

Different modes of anthracycline interaction with topoisomerase II von Jensen, Peter Buhl, Sørensen, Boe Sandahl, Sehested, Maxwell, Demant, Erland J.F., Kjeldsen, Eigil, Friche, Ellen, Hansen, Heine Høi

Volltext